# OnCo record paper-patil-lancet-glob-health (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-patil-lancet-glob-health/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-patil-lancet-glob-health" ;
  schema:name "Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial"@en ;
  schema:description "Paper cited by one trial page, indexed on Europe PMC as PubMed record 32827483 and published in The Lancet Global Health; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-patil-lancet-glob-health/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s2214-109x(20)30275-8>, <https://pubmed.ncbi.nlm.nih.gov/32827483/>, <https://europepmc.org/article/MED/32827483> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s2214-109x(20)30275-8> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Patil V, Noronha V, Dhumal SB, et al." ;
  onco:trials <https://onco.cc/trials/metronomic-vs-cisplatin-tmh/> ;
  onco:journals <https://onco.cc/journals/lancet-global-health/> .